Research Funding from the Genetic Engineering Foundation – Dr. Georg and Ingeburg Scheel Foundation

The Genetic Technology Foundation – Dr. Georg and Ingeburg Scheel Foundation supports scientific research projects nationwide in the field of human medical genetic technology, focusing on diseases previously considered incurable such as cancer, Parkinson’s, diabetes, cardiovascular diseases, and multiple sclerosis. As a grant provider, it promotes innovative approaches to the development of new therapeutic options, thereby strengthening the interface between research & innovation, science, health, as well as labor & social affairs. The funding program is aimed at educational institutions, non-profit organizations, and companies and is characterized by its continuous submission possibility. Projects involving human cloning are excluded. Applications may be submitted at any time.

Particularly targeted are scientists and research institutes whose projects not only demonstrate a high degree of innovation but also possess the potential to therapeutically address previously incurable conditions. Prerequisites for funding include a clear thematic connection to human medical genetic technology and a detailed project description within the context of the aforementioned diseases. Evaluation criteria include scientific relevance, innovation potential, and the qualifications of the applicants. Through transparent grant allocation, the foundation contributes to strengthening forward-looking research landscapes and promotes cooperation between research institutions, non-profit organizations, and industry.